Ameriprise’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Hold |
33,751
| – | – | ﹤0.01% | 3839 |
|
|
2025
Q1 | $101K | Sell |
33,751
-52,418
| -61% | -$157K | ﹤0.01% | 3846 |
|
|
2024
Q4 | $289K | Sell |
86,169
-11,900
| -12% | -$39.9K | ﹤0.01% | 3716 |
|
|
2024
Q3 | $329K | Sell |
98,069
-3,724
| -4% | -$12.5K | ﹤0.01% | 3603 |
|
|
2024
Q2 | $337K | Sell |
101,793
-4,025
| -4% | -$13.3K | ﹤0.01% | 3556 |
|
|
2024
Q1 | $428K | Buy |
105,818
+52,329
| +98% | +$211K | ﹤0.01% | 3468 |
|
|
2023
Q4 | $163K | Buy |
53,489
+11,601
| +28% | +$35.4K | ﹤0.01% | 3749 |
|
|
2023
Q3 | $126K | Sell |
41,888
-7,240
| -15% | -$21.7K | ﹤0.01% | 3767 |
|
|
2023
Q2 | $184K | Buy |
49,128
+5,825
| +13% | +$21.8K | ﹤0.01% | 3741 |
|
|
2023
Q1 | $145K | Buy |
43,303
+20,343
| +89% | +$68.1K | ﹤0.01% | 3786 |
|
|
2022
Q4 | $111K | Sell |
22,960
-5
| -0% | -$24 | ﹤0.01% | 3798 |
|
|
2022
Q3 | $131K | Buy |
+22,965
| New | +$131K | ﹤0.01% | 3771 |
|
|
2021
Q4 | – | Sell |
-25,266
| Closed | -$885K | – | 3956 |
|
|
2021
Q3 | $885K | Buy |
+25,266
| New | +$885K | ﹤0.01% | 3213 |
|
|
2021
Q2 | – | Sell |
-62,365
| Closed | -$3.85M | – | 3888 |
|
|
2021
Q1 | $3.85M | Sell |
62,365
-48,811
| -44% | -$3.01M | ﹤0.01% | 2543 |
|
|
2020
Q4 | $4.65M | Buy |
+111,176
| New | +$4.65M | ﹤0.01% | 2323 |
|